Bitcoin 958.07
$57,983.00 1.65233%
Ethereum 304.37
$4,603.04 6.61233%
XRP 0.03
$1.01 3.2866%
Zcash -14.03
$228.77 -6.13086%
Monero 27.69
$264.85 10.45558%
Tether 0.00
$1.00 -0.06429%
Elite 0.00
$0.00 4.93016%
Accelerating Biotech Breakthroughs
Token sale completed on 10 September
Goal: 20,000,000 USD
Website Whitepaper

There are many challenges facing the biotech industry today, such as quality assurance, counterfeiting and research intransparency. GENEXI is determined to deliver a holistic solution in the form of a transparent and comprehensive blockchain-based ecosystem on to the market. Within GENEXI Ecosystem biotech start-ups and projects will be able to find financial and advisory support to establish and scale-up their production. Upon entering the GENEXI Platform, distributors will be able to provide their services and build networks with vendors, while regular customers will gain an access to complete immutable data about the products. At the same time, third-party service providers will be able to present their support to other participants of the community. GENEXI plans to integrate its unique blockchain solution throughout the entire supply chain management process in order to fight drug counterfeit, fraud and quality manipulation and ensure full transparency at every level.

Token Sale: 01 June — 10 September
Ticker
ICO Token Price
Whitelist
Min/Max Personal Cap
Accepts
Screenshots
Short review
Number of team Members

Add a comment

Member of The Internet Defense League